Daniel DeSalvo, MD
- Diabetes and Endocrinology
Director of Strategic Collaboration, Texas Children’s Diabetes & Endocrine Care Center
Medical Leadership Team, Beta Cell Preservation Center of Excellence
Associate Professor, Baylor College of Medicine
Phone:
832-822-3670
Medical Center
Phone:
281-282-1900
Clear Lake
Languages: English
Departments:
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
940 Clear Lake City Boulevard
Suite 200
Webster, TX 77598
Get to know Daniel DeSalvo, MD
Dr. Daniel DeSalvo is a Pediatric Endocrinologist and Clinical Researcher specializing in type 1 diabetes, diabetes technology and strategies to improve outcomes for children and adolescents living with diabetes. His clinical and research work focuses on advancing the use of automated insulin delivery systems, continuous glucose monitoring and disease-modifying therapies to reduce the burden of diabetes management for patients and families. Dr. DeSalvo leads and collaborates on clinical trials and quality improvement initiatives aimed at accelerating the translation of innovative diabetes therapies into routine clinical practice.
In addition to his clinical responsibilities, Dr. DeSalvo is actively involved in clinical research, program development and the training and mentorship of students, trainees and healthcare professionals. He regularly presents at regional and national meetings and works closely with academic, industry and community partners to advance the care of children and adolescents with diabetes.
Personal Statement
I believe that caring for children and adolescents with diabetes is about much more than managing blood glucose levels. My goal is to partner with children and families to develop practical, personalized treatment plans that fit their lives, reduce the burden of diabetes management and help every child thrive. I strive to create an environment where families feel heard, supported and empowered to make informed decisions about their care. I am passionate about helping patients benefit from advances in diabetes technology and emerging therapies that have the potential to improve both health outcomes and quality of life. I believe that excellent diabetes care combines evidence-based medicine, innovation, education and strong relationships built on trust and communication.
As a physician-scientist, I am committed to advancing pediatric diabetes care through clinical research and quality improvement initiatives that bring new discoveries from the research setting into everyday clinical practice. I consider it a remarkable privilege to care for children living with diabetes, and I am committed to supporting them throughout every stage of their journey.
Clinical Interests
Pediatric Diabetes
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Stanford Health Care Stanford University Program | Fellowship | Pediatric Endocrinology | 2015 |
| The George Washington University School of Medicine / Children’s National Medical Center | Residency | Pediatrics | 2012 |
| The George Washington University School of Medicine / Children’s National Medical Center | Residency | Chief Resident | 2012 |
| Texas A&M University Health Science Center College of Medicine | Medical School | Doctor of Medicine | 2008 |
| Baylor University | Bachelors | Bachelor of Arts in Political Science | 2003 |
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics | Member |
| American Diabetes Association | Member |
| National Research Mentoring Network | Member |
| Pediatric Endocrine Society of Texas, Oklahoma, Louisiana, and Arkansas | Member |
| Texas Children’s Research Institute | Faculty Member |
Board Certifications
| Title |
|---|
| American Board of Pediatrics |
| Board Certified in Pediatric Endocrinology |
Honors and awards
- 2026
-
Quality Improvement and Patient Safety - QIPS - Scholar Award, Baylor College of Medicine
- 2025
-
Patient Experience Award, Texas Children's Hospital
- 2025
-
Community Partner of the Year Award, Breakthrough T1D Southern Texas Chapter
- 2025
-
SOAR Research Mentor Champion For Medical Students, Baylor College of Medicine
- 2025
-
Ninja Mentor Award for Outstanding Peer Mentorship, Baylor College of Medicine/Texas Children's Hospital
- 2025
-
Principal Investigator of the Year Award, Baylor College of Medicine/Texas Children's Hospital Center for Research Advancement
- 2024
-
Faculty Educational Award for Best Lecture in Pediatric Endocrinology, Baylor College of Medicine
- 2023
-
Health Disparities Top Abstract Award, 83rd Scientific Sessions, American Diabetes Association
- 2023
-
Provider, Excellence Award, Texas Children's Award
- 2023
-
Outstanding Pediatric Principal Investigator Award, T1D Exchange QI Collaborative
- 2022
-
President’s Select Abstract Award, 82nd Scientific Sessions, American Diabetes Association
- 2020
-
Award for Outstanding Quality Improvement Team (Principal Investigator), T1D Exchange
- 2020
-
Pediatric Device Faculty Seed Grant Awardee, SouthWest Pediatric Device Consortium / Baylor College of Medicine / Texas Children’s Hospital
- 2020
-
Faculty Educational Award, Best Outpatient Teacher in Pediatric Endocrinology, Baylor College of Medicine
- 2020
-
Early Career Faculty Award for Excellence in Patient Care, Baylor College of Medicine
- 2019
-
Health Care Hero Award, Houston Business Journal
- 2019
-
Faculty Educational Award for Excellence in Teaching, Baylor College of Medicine
- 2017
-
Outstanding Faculty Teaching Award, BCM Endocrinology Fellowship, Baylor College of Medicine
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Reviews
Research interests
Diabetes technology, automated insulin delivery systems, disease-modifying therapies for type 1 diabetes, and clinical strategies that improve outcomes and reduce the burden of care for children and adolescents living with diabetes
DeSalvo DJ, Linde NM, Sickler J, Villegas C, Cescon M. Safety and Glycemic Outcomes Among Youth with New-Onset Type 1 Diabetes Using a Tubeless Automated Insulin Delivery System. Journal of Diabetes Research, 2026;2026(1):e2896084. PMID: 42083439
DeSalvo DJ, Bode BW, Forlenza GP, Laffel LM, Buckingham BA, Criego AB, Schoelwer M, MacLeish SA, Sherr JL, Hansen DW, Ly TT. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod 5 Automated Insulin Delivery System. Diabetes Technology & Therapeutics. 2024;26(6):383-393. PMID: 38277156.
DeSalvo DJ, Noor N, Xie C, Corathers S, Majidi S, McDonough RJ, Polsky S, Izquierdo R, Rioles N, Weinstock R, Obrynba K, Roberts A, Vendrame F, Sanchez F, Ebekozien O. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data from a T1D Exchange Real-World Observational Study. Journal of Diabetes Science and Technology. 2023;17(2):322-328.
DeSalvo DJ, Lanzinger S, Noor N, Steigleder-Schweiger C, Ebekozien O, von Sengbusch K, Jones NHY, Laubner K, Maahs DM, Holl R. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the DPV Initiative and T1D Exchange Quality Improvement Collaborative. Diabetes Technology & Therapeutics. 2022;24(12):920-924. PMID: 35947079.
Alarcon G, Lyons S, Buckingham D, Erraguntla M, Sonabend R, DeSalvo DJ. ROCKET T1D Remote Monitoring Program: Launching Diabetes Management Habits in New-Onset Diabetes. Clinical Diabetes, 2025;43(3):371-377. PMID: 40741457
Corathers SD, DeSalvo DJ. Therapeutic Inertia in Pediatric Diabetes: Challenges to and Strategies for Overcoming Acceptance of the Status Quo. Diabetes Spectrum, 2020;33(1):22-30. PMID: 32116450